Loading…
Pharmaceuticals Contract Development and Manufacturing Organization (CDMO) · NSE · period ending 2026-03-31
Loading chart…
✓ Core business is permissible and non-compliant income is 0.51% of revenue (limit 5%).
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Debt / 36-month avg market cap | 0% | < 33% | Pass |
| Cash + interest-bearing securities / 36-month avg market cap | 13.62% | < 33% | Pass |
| Accounts receivable / 36-month avg market cap | 3.97% | < 33% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up free0.51% of any dividend from BLUEJET should be given to charity. Calculate your amount →
Compliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.
Recent 1–3 month returns are very strong but 6-month performance is still negative and the stock trades far from its high with 50-day below 200-day, implying a volatile recovery within a broader sideways-to-repair phase. Positive aviation sentiment coincides with the recent improvement but does not yet align with a fully established trend change.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.